In conclusion, the data provided here indicates that SELENOF is a prostate cancer tumor suppressor able to alter the transformed phenotype of human prostate epithelial cells and may contribute to the disparity in prostate cancer mortality that exists among men of African descent. The gene discussed is SELENOF; the disease is prostate carcinoma.